Home/Filings/4/0000899243-22-001474
4//SEC Filing

Ahuja Aparna 4

Accession 0000899243-22-001474

CIK 0001492674other

Filed

Jan 9, 7:00 PM ET

Accepted

Jan 10, 4:19 PM ET

Size

4.7 KB

Accession

0000899243-22-001474

Insider Transaction Report

Form 4
Period: 2022-01-06
Ahuja Aparna
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2022-01-06$0.48/sh61,988$29,754107,611 total
Footnotes (1)
  • [F1]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to pay the tax liability arising from the vesting and settlement of restricted stock units on January 5, 2022.

Issuer

T2 Biosystems, Inc.

CIK 0001492674

Entity typeother

Related Parties

1
  • filerCIK 0001840844

Filing Metadata

Form type
4
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 4:19 PM ET
Size
4.7 KB